Jeff Yass’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-18,600
Closed -$13K 13503
2024
Q1
$13K Sell
18,600
-20,900
-53% -$23.6K ﹤0.01% 11883
2023
Q4
$69.1K Sell
39,500
-37,300
-49% -$54.5K ﹤0.01% 11555
2023
Q3
$111K Buy
76,800
+20,300
+36% +$50.8K ﹤0.01% 10836
2023
Q2
$147K Sell
56,500
-30,400
-35% -$90.9K ﹤0.01% 10600
2023
Q1
$320K Buy
86,900
+45,700
+111% +$192K ﹤0.01% 9578
2022
Q4
$72.9K Sell
41,200
-24,900
-38% -$66.2K ﹤0.01% 11194
2022
Q3
$262K Buy
66,100
+17,700
+37% +$109K ﹤0.01% 10149
2022
Q2
$268K Buy
48,400
+2,800
+6% +$22.9K ﹤0.01% 9874
2022
Q1
$669K Buy
45,600
+1,400
+3% +$18.7K ﹤0.01% 8206
2021
Q4
$698K Sell
44,200
-155,000
-78% -$3.72M ﹤0.01% 8265
2021
Q3
$6.4M Buy
199,200
+92,800
+87% +$3.26M ﹤0.01% 3534
2021
Q2
$4.42M Sell
106,400
-35,900
-25% -$1.47M ﹤0.01% 4253
2021
Q1
$7.23M Buy
142,300
+107,700
+311% +$5.63M ﹤0.01% 3295
2020
Q4
$1.12M Buy
+34,600
New +$491K ﹤0.01% 6453

Other funds holding DMTK

Jeff Yass's DMTK Position: Q2 2024 in Review

Jeff Yass sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 13,194 shares — an estimated $9.26K sold.

Jeff Yass first reported a position in DMTK in Q1 2020 and held it in 15 quarters. The position peaked at $12.8M in Q1 2021. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • Jeff Yass reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Jeff Yass sold 13,194 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $9.26K.
  • Jeff Yass first reported a position in DermTech, Inc. Common Stock in Q1 2020 and held it in 15 quarters.
  • Jeff Yass's DermTech, Inc. Common Stock position peaked at $12.8M in Q1 2021.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.